(D5BG) Xtrackers II - EUR - Ratings and Ratios
Corporate Bonds, Euro Corporate Bonds, Fixed-Income Securities
Description: D5BG Xtrackers II - EUR
The Xtrackers II - EUR Corporate Bond UCITS ETF, traded on XETRA under the ticker symbol D5BG, is an investment vehicle designed to track the Morningstar EZN Corp Bd GR EUR index. This ETF provides exposure to a diversified portfolio of EUR-denominated corporate bonds, primarily issued by European companies.
As a seasoned Trading Analyst, I can infer that the ETFs underlying index likely comprises a broad range of investment-grade corporate bonds, potentially including securities from various sectors and industries. The funds Assets Under Management (AUM) stand at approximately €3.54 billion, indicating a moderate level of liquidity and a sizable presence in the market.
Analyzing the technical data, we can observe that the ETFs price is currently at €160.23, slightly above its 20-day Simple Moving Average (SMA) of €159.60. The 50-day SMA is at €158.91, while the 200-day SMA is at €157.53, indicating a longer-term uptrend. The Average True Range (ATR) is relatively low at 0.48, corresponding to a percentage of 0.30%, suggesting stable price movements. Given these indicators, it is likely that the ETF will continue to trade within a narrow range in the short term.
Using a combination of technical and fundamental analysis, I forecast that the Xtrackers II - EUR Corporate Bond UCITS ETF will maintain its current price level or potentially appreciate slightly in the near future. The ETFs tracking of a diversified corporate bond index, coupled with its moderate AUM and stable price movements, suggests a relatively low-risk investment opportunity. However, it is essential to monitor changes in interest rates, credit spreads, and overall market conditions, as these factors can impact the ETFs performance. A potential trading strategy could involve buying the ETF on dips towards the 20-day SMA, with a target price around €161.00, while setting a stop-loss around €158.50 to limit potential losses.
Additional Sources for D5BG ETF
D5BG ETF Overview
Market Cap in USD | 4,693m |
Category | EUR Corporate Bond |
TER | 0.13% |
IPO / Inception | 2010-02-23 |
D5BG ETF Ratings
Growth Rating | 6.87 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 10.2 |
Analysts | - |
Fair Price Momentum | 150.08 EUR |
Fair Price DCF | - |
D5BG Dividends
Currently no dividends paidD5BG Growth Ratios
Growth Correlation 3m | 91.6% |
Growth Correlation 12m | 91% |
Growth Correlation 5y | -39.9% |
CAGR 5y | 0.22% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | 0.70 |
Alpha | 0.43 |
Beta | 0.039 |
Volatility | 2.85% |
Current Volume | 9.8k |
Average Volume 20d | 7.2k |
Stop Loss | 156 (-3%) |
As of July 16, 2025, the stock is trading at EUR 160.80 with a total of 9,849 shares traded.
Over the past week, the price has changed by -0.10%, over one month by +0.23%, over three months by +1.56% and over the past year by +5.21%.
Neither. Based on ValueRay´s Analyses, Xtrackers II - EUR is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 6.87 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of D5BG is around 150.08 EUR . This means that D5BG is currently overvalued and has a potential downside of -6.67%.
Xtrackers II - EUR has no consensus analysts rating.
According to our own proprietary Forecast Model, D5BG Xtrackers II - EUR will be worth about 162.1 in July 2026. The stock is currently trading at 160.80. This means that the stock has a potential upside of +0.8%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 162.1 | 0.8% |